(833) 317-6278 
In the British Heart Foundation SENIOR-RITA (Older Patients with Non–ST-Segment Elevation Myocardial Infarction Randomized Interventional Treatment) trial, patients 75 years of age or older with non–ST-segment elevation myocardial infarction (NSTEMI) were randomly assigned to receive treatment that was based on a conservative-treatment strategy or an invasive-treatment strategy of coronary-artery angiography (and percutaneous coronary intervention [PCI] or coronary-artery bypass grafting, if indicated).
The New England Journal of Medicine (NEJM) is a prestigious weekly medical journal that serves as a leading authority on healthcare and pharmaceutical research. Published by the Massachusetts Medical Society, NEJM provides physicians, educators, researchers, and other healthcare professionals with peer-reviewed scientific content, expert commentary, and clinical insights.
Covering a wide range of topics within the healthcare and pharmaceutical industries, NEJM's scholarly articles delve into scientific discoveries, medical advancements, health and wellbeing practices, and regulatory policies. The journal's rigorous peer-review process ensures that the published research is backed by robust data and thorough analysis.
In addition to original research studies, NEJM features expert commentary, literature reviews, and legal and regulatory updates, offering readers a comprehensive understanding of the latest developments in the medical field. The journal's content also extends to areas such as food and beverage, and product promotions related to healthcare and pharmaceuticals.
NEJM's audience comprises medical professionals, researchers, academicians, and industry stakeholders who rely on its authoritative content to stay informed, make informed decisions, and advance their knowledge and practice in their respective areas of expertise.
